[Fixed-dose compounds and the secondary prevention of ischemic heart disease].

Abstract

Worldwide, the leading causes of death are ischemic heart disease and stroke. Moreover, patients with several risk factors or a history of ischemic heart disease are at a high risk of coronary event recurrence. There is evidence that primary cardiovascular disease prevention programs are effective when applied to the general population. However, therapeutic… (More)
DOI: 10.1016/j.recesp.2011.02.027

Topics

  • Presentations referencing similar topics